Biomat-IN project general bilan (March 2015)


Closing of the Interreg Biomat-IN project - Lille - March 18th 2015

The aftermath of 4 years of financing, representing an investment of over 1.11M€ is the following: support tools to structure the sector and for market perception, elaboration of a technology offer and establishment of a long-lasting transnational support framework to assist the sector’s SMEs.

Through the Biomat-IN project, actions to improve transnational cooperation in North-Western Europe were conducted to strengthen the territorial framework for innovation and transfer of knowledge in the biomaterials field. 5 leading regional human health clusters (Eurasanté and Atlanpole Biotherapies in France, BioRegio STERN in Germany, MedlinkEM in UK, LIOF in the Netherlands), therefore over 250 biomaterials SMEs, worked together.

Biomat-IN project resulted in:

  • Creation and online distribution of toolkits providing SMEs from partner regions with key information to ease their access into transnational markets: online directory of the biomaterial industry (126 SMEs and 67 research centres), market information and trends, funding instruments, regulations.
  • Stimulation of collaborations and emergence of transnational partnerships within the biomaterial industry: identification and spread through the needs and technology offer network (online Biomaterial Technology Marketplace), organisation of 9 Special Interest Groups on specific biomaterial-related topics.
  • Creation of a durable transnational framework in order to assist SMEs of the biomaterials field in the implementation of their transnational collaborative R&D project ideas: organisation of a “Call for Vouchers” to allow transnational R&D projects to benefit from feasibility studies (allocation of 6 vouchers).

Biomaterials (eg breast implants, prosthetic hips or knees, wound dressings with active ingredients release, contact lenses) are intended to interface with biological systems. Directly linked to the extension of life expectation and the need for a better quality of life, biomaterials are indeed more and more used in innovative medical applications. They are already playing an important role in medical devices development, such as prostheses, tissue repair, drug delivery systems and diagnostic techniques. Based on advanced polymer chemistry techniques, biotechnology, gene therapy, cell and tissue engineering, innovative biomaterials development will require new strategies for multidisciplinary research, involving academics and industrial partners.

About Biomat-IN: project resulting from the Interreg IVB North Western Europe projects call, supported by European Regional Development Fund (ERDF). 4 years of support (from March 2011 to March 2015), representing a total budget of over 1,11 million euros.

contacts of the regional partners


More about us

Biomaterials, materials intended to interface with biological systems, are now used in many medical applications, including: contact lenses, dental restoration, heart valves and prosthetic hips …

Directly linked to the extension of life expectancy and the need for a better quality of life, biomaterials are being used more and more in innovative medical applications...

Based on advanced techniques of polymer chemistry, biotechnology, cell and tissue engineering, the application of innovative biomaterials will require new strategies for multidisciplinary research, involving academics and industrial partners.

Biomat-IN gathers 5 European clusters willing to pool their resources in order to foster innovation in the field of biomaterials through transnational cooperation: Eurasanté and Atlanpole Biotherapies in France, Bioregio Stern in Germany, Medilink EM in the UK and LIOF in the Netherlands.

> Download our leaflet

> Download our mid-term evaluation report of the Biomat-IN project





| Online database

| Infos on the biomaterials market

| Infos on financial instruments

| Infos on regulations

next events


Wednesday, March 18th 2015, From 2:00 pm to 6:00 pm

1st Floor, Espace Inkermann-Châtillon, 5, rue Gauthier Châtillon, 59000 LILLE

The partners of the Biomaterials Innovation Network (Biomat-IN) have pleasure in inviting you to their Closing Event which will take place at Espace Inkermann-Châtillon on Wednesday 18th of March 2015, from 2 pm to 6 pm, in Lille, France.

The Biomat-IN project, launched in March 2011,
gathers 5 European clusters (Eurasanté and Atlanpole Biotherapies from France, BioRegio STERN from Germany, MedilinkEM from England and LIOF from the Netherlands) willing to pool their ressources in order to foster innovation in the field of biomaterials through transnational cooperation.

This event will be an opportunity to present the results of this cross-border cooperation and its prospects. It will start by a press conference and the projection of a movie which will present you interviews of actors of the 5 partners regions involved in a collaborative project which received a voucher through the Biomat-IN project and will be closed by a cocktail.

This event is free of charge and is supported by Interreg IVB.

To see the programme and to register click here

For more information, please contact Christelle PAYEN, Business Developer Innovation, GIE Eurasanté, +33 328 559 060 -


Medilink East Midlands)
BioCity Nottingham
Pennyfoot Street
Tel: +44 (0) 115 912 4337
Fax: +44 (0) 115 912 4331

ATLANPOLE Biotherapies
Château de la Chantrerie
95, Route de Gachet
B.P. 90702
Tel : +33(0) 2 40 25 27 21
Fax :+33(0) 2 40 25 10 88

310 av. Eugène Avinée
59120 Loos-les-Lille
Tel. : +33(0) 328 559 060
Fax : +33(0) 328 559 061

NV Industriebank LIOF
Limburgse Ontwikkelings- en investeringsmaatscha- ppij. Postbus 1310, 6201 BH Maastricht
Boschstraat 76
Tel: +31 (043) 3 280 280
Fax:+31 (043) 3 280 200

BioRegio STERN Management GmbH
Friedrichstr. 10
D-70174 Stuttgart
Tel: +49-711-87035426
Fax: +49-711-87035444

  Join the Biomat-IN linkedIN Group
  Join the Biomat-IN linkedIN Group